Nilotinib Vs Nilotinib Plus Pegylated Interferon a (Peg-IFN) Induction and Nilotinib or Peg-IFN Maintenance Therapy for Newly Diagnosed BCR-ABL1 Positive Chronic Myeloid Leukemia Patients in Chronic Phase (TIGER Study): The Addition of Peg-IFN Is Associated with Higher Rates of Deep Molecular Response
Hochhaus A, Burchert A, Saussele S, Baerlocher GM, Brummendorf TH, Rosee PL, Heim D, Krause S, Le Coutre PD, Niederwieser D, Lange T, Fabarius A, Hanel M, Stegelmann F, Mayer J, Gil A, Himsel D, Hasford J, Hehlmann R, Ernst T, Fabisch C, Pfirrmann M (2019)
Publication Type: Conference contribution
Publication year: 2019
Journal
Publisher: AMER SOC HEMATOLOGY
City/Town: WASHINGTON
Conference Proceedings Title: BLOOD
Event location: Orlando, FL
DOI: 10.1182/blood-2019-130043
Authors with CRIS profile
Involved external institutions
Ludwig-Maximilians-Universität (LMU)
Germany (DE)
Klinikum Chemnitz
Germany (DE)
Universitätsklinikum Ulm
Germany (DE)
Universitätsklinikum Jena
Germany (DE)
Universitätsklinikum Mannheim
Germany (DE)
Universität Leipzig
Germany (DE)
ELN Foundation
Germany (DE)
Universitätsspital Basel
Switzerland (CH)
Asklepios Klinik Weissenfels
Germany (DE)
Universität Bern
Switzerland (CH)
Schwarzwald-Baar Klinikum
Germany (DE)
Charité - Universitätsmedizin Berlin
Germany (DE)
Masaryk University
Czech Republic (CZ)
Philipps-Universität Marburg
Germany (DE)
Universitätsklinikum Aachen (UKA)
Germany (DE)
Germany (DE)
Klinikum Chemnitz
Germany (DE)
Universitätsklinikum Ulm
Germany (DE)
Universitätsklinikum Jena
Germany (DE)
Universitätsklinikum Mannheim
Germany (DE)
Universität Leipzig
Germany (DE)
ELN Foundation
Germany (DE)
Universitätsspital Basel
Switzerland (CH)
Asklepios Klinik Weissenfels
Germany (DE)
Universität Bern
Switzerland (CH)
Schwarzwald-Baar Klinikum
Germany (DE)
Charité - Universitätsmedizin Berlin
Germany (DE)
Masaryk University
Czech Republic (CZ)
Philipps-Universität Marburg
Germany (DE)
Universitätsklinikum Aachen (UKA)
Germany (DE)
How to cite
APA:
Hochhaus, A., Burchert, A., Saussele, S., Baerlocher, G.M., Brummendorf, T.H., Rosee, P.L.,... Pfirrmann, M. (2019). Nilotinib Vs Nilotinib Plus Pegylated Interferon a (Peg-IFN) Induction and Nilotinib or Peg-IFN Maintenance Therapy for Newly Diagnosed BCR-ABL1 Positive Chronic Myeloid Leukemia Patients in Chronic Phase (TIGER Study): The Addition of Peg-IFN Is Associated with Higher Rates of Deep Molecular Response. In BLOOD. Orlando, FL, US: WASHINGTON: AMER SOC HEMATOLOGY.
MLA:
Hochhaus, Andreas, et al. "Nilotinib Vs Nilotinib Plus Pegylated Interferon a (Peg-IFN) Induction and Nilotinib or Peg-IFN Maintenance Therapy for Newly Diagnosed BCR-ABL1 Positive Chronic Myeloid Leukemia Patients in Chronic Phase (TIGER Study): The Addition of Peg-IFN Is Associated with Higher Rates of Deep Molecular Response." Proceedings of the 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Orlando, FL WASHINGTON: AMER SOC HEMATOLOGY, 2019.
BibTeX: Download